{
    "clinical_study": {
        "@rank": "129574", 
        "arm_group": {
            "arm_group_label": "Candidemia", 
            "description": "Candidemia is defined as the presence of growth of any candida species in at least one blood culture obtained by either peripheral venipuncture or through an indwelling central venous catheter."
        }, 
        "brief_summary": {
            "textblock": "Candidemia has emerged as an important cause of hospital-associated blood-stream infection\n      in children. The purpose of this study was to identify differences in distribution of\n      candida species, risk factors, treatment, and clinical outcome of candidemia in children.\n      This study in children \u226418 years with blood culture proven candidemia identified between\n      2004 and 2012. Analyses included the determination of causative candida species, resistance\n      to antifungals and clinical outcome, as well as the identification of potential risk factors\n      associated with candidemia."
        }, 
        "brief_title": "Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Candidemia", 
        "condition_browse": {
            "mesh_term": "Candidemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presence of growth of any candida species in at least one blood culture\n\n        Exclusion Criteria:\n\n          -  Febrile neutropenic patients who were using empirical antifungal agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Children diagnosed with candidemia were included in our hospital between Jan 2004 and Dec\n        2012."
            }
        }, 
        "enrollment": {
            "#text": "248", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02088476", 
            "org_study_id": "HUTF06"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "candidemia", 
            "children", 
            "mortality", 
            "risk factors"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06100"
                }, 
                "name": "Hacettepe University Faculty of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The presence or absence of potential risk factors for candidemia such as an indwelling central venous catheter (CVC), use of antibiotics (administered for >72 hours), use of antifungals (administered for >24 hours), immunosuppressants, total parenteral nutrition (TPN), admission to the intensive care unit (ICU), mechanical ventilation, neutropenia, hypoalbuminemia and hypophosphatemia.", 
            "measure": "Risk factors of candidemia", 
            "safety_issue": "No", 
            "time_frame": "up to 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02088476"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hacettepe University", 
            "investigator_full_name": "Eda Karadag Oncel, MD", 
            "investigator_title": "Hacettepe University Department of Pediatric Infectious Diseases", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Death which ensues within 30 days of the onset of candidemia with no apparent alternative cause is recognized as a candidemia-attributable mortality. Patients who died and survived were compared according to candida species (C.albicans, C. parapsilosis, C. tropicalis, C. sake, C.glabrata).", 
            "measure": "Prognosis according to candida species", 
            "safety_issue": "No", 
            "time_frame": "up to 3 months"
        }, 
        "source": "Hacettepe University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hacettepe University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2004", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}